PFO - Patent Foramen Ovale Clinical Trial
Official title:
Amplatzer™Trevisio™Delivery System Post-Approval Study
A single-arm, non-randomized, multi-center clinical study of the Amplatzer™ Trevisio™ Intravascular Delivery System for facilitating percutaneous, transcatheter implantation of the Amplatzer™ Occluder Devices. NOTE: The enrollment for the VSD cohort is still recruiting (3 subjects at this moment); therefore, the overall status of the study is Recruiting.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05529901 -
Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder
|
||
| Active, not recruiting |
NCT04029233 -
The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO
|
||
| Active, not recruiting |
NCT04349995 -
Amplatzer PFO Occluder Post-marketing Surveillance Study
|
||
| Recruiting |
NCT06046508 -
Migraine With Aura and Patent Foramen Ovale: Identification of Biomarkers to Select Patients In Whom Intervention Would Be Beneficial (MANET)
|
||
| Recruiting |
NCT03821129 -
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
|
N/A | |
| Not yet recruiting |
NCT06203873 -
A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine
|
N/A | |
| Recruiting |
NCT06033937 -
COMPETE Cohort Study
|
||
| Active, not recruiting |
NCT04100135 -
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
|
N/A | |
| Recruiting |
NCT04946734 -
Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine
|
Phase 3 |